News | November 23, 2011

Endovascular Approach Pronounced Best Approach to Dealing with Para?Anastomotic Aneurysms

November 23 2011 – At the 2011 VEITH symposium, Arno von Ristow, M.D., department of vascular and endovascular surgery, Centervasc-Rio & Clinica Sorocaba, Catholic University of Rio de Janeiro, Brazil, presented some strong findings regarding the use of endovascular techniques to deal with the management of para-anastomotic aneurysms (aneurysms that can form above or below the graft at a variety of time points after open abdominal aortic aneurysm [AAA] repair). Patients who undergo open aneurysm repair are not completely cured of their disease. New aneurysms can develop proximal and distal to the graft. However, a direct surgical approach to treat these new aneurysms is particularly challenging. The development of endovascular techniques has enabled a minimally invasive approach to many of these aneurysms.

Ristow reviewed the experience of his vascular and endovascular surgery center in treating para-anastomotic aneurysms. A total of 53 were treated, with 58 percent involving the aorta and 42 percent in the iliac arteries. The operative approach was individualized and varied according to the anatomy of the aneurysms. The majority of the aortic grafts were custom made for each patient by Nano Endoluminal. All aneurysms were successfully treated and the repair has been durable up to 42 months. In hospital mortality was 3.4 percent. Because of this encouraging result, Ristow said, “Endovascular approach is the best way to deal with para-anastomotic aneurysms.”

For more information: www.VEITHpress.org

Related Content

Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a new, low-profile thoracic aortic endograft is safe and effective in the treatment of descending thoracic aortic aneurysm or penetrating atherosclerotic ulcer (PAU) diseases.
News | Endovascular Aortic Repair | May 12, 2021
May 12, 2021 — Preliminary results of a clinical trial, presented today at the ...
Medtronic Recalls Unused Valiant Navion Thoracic Stent Grafts
News | Endovascular Aortic Repair | February 23, 2021
February 23, 2021 — Medtronic has voluntarily issued a global recall of unused...
The researchers used high resolution cross-sectional imaging with CT or MRI to assess 225 men with abdominal aortic aneurysm. Follow-up lasted, on average, more than three years.  Slightly more than half of patients had an intraluminal thrombus. The aneurysms of those with intraluminal thrombus were larger at baseline and grew by a rate of 2 mm per year, twice as fast as the 1 mm per year growth rate in people without intraluminal thrombus.
News | Endovascular Aortic Repair | January 29, 2020
January 29, 2020 – The presence of a blood clot on the wall of the aorta in people with...
The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for endovascular treatment of pathologies extending or involving the aortic arch.  #VIVA19 #VIVA2019

The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for endovascular treatment of pathologies extending or involving the aortic arch. 

News | Endovascular Aortic Repair | November 11, 2019
November 7, 2019 — The Endospan Ltd.
Obese Patients Have More Post-Op Problems Following AAA Repair
News | Endovascular Aortic Repair | November 21, 2018
New research in the December edition of the Journal of Vascular Surgery suggests significant increase in morbidities in...
FDA Classifies Previous Endologix AFX Safety Notice as Class I Recall
News | Endovascular Aortic Repair | October 08, 2018
Endologix Inc. received notice that the U.S. Food and Drug Administration (FDA) has classified a voluntary recall...
The Gore TAG stent graft used in TEVAR aortic repair procedures for aneurysms.

The Gore TAG stent graft used for endovascular aortic aneurysm repair procedures.

Feature | Endovascular Aortic Repair | February 05, 2018 | Andrei Churyla, M.D., S. Chris Malaisrie, M.D.
Here are several considerations for physicians when choosing...
Endologix Receives IDE Approval for EVAS2 Confirmatory Clinical Study
News | Endovascular Aortic Repair | October 19, 2017
Endologix Inc. received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA...
New Paper Highlights Success of Advanced Treatments in Complex Aortic Aneurysm Repair
News | Endovascular Aortic Repair | May 23, 2017
Significant success has been achieved in treating complex proximal aneurysms using a combination of fenestrated and...